The size of the Latin American infection control market is forecasted to be growing at a healthy CAGR from 2021 to 2026.
Preventing infections can reduce nosocomial infections by 30%. Nosocomial infections (HAIs) are more common in intensive care units and are significantly associated with increased morbidity and mortality. In addition, infection control affects the recovery of the patient.
Y-O-Y growth in the incidence of HAIs, increase in the number of surgeries, increase in the geriatric population, and increased cases of chronic diseases such as cancer, diabetes, obesity, cardiac and respiratory disorders, and the growing need for sterilization and disinfection of food are majorly driving the Latin American infection control market.
The increasing incidence of hospital-acquired infections is expected to drive the growth of the Latin American infection control market. Additionally, growing awareness of various infections and increasing hospital admissions, owing to rapid growth in the geriatric population, are other factors that are expected to further drive the growth of the Latin American infection control market during the forecast period. In addition, the increasing demand for non-disposable surgical equipment in hospitals/clinics and an increasing number of surgical procedures are expected to drive the future growth of the Latin American infection control market during the forecast period.
Technological advancements and drug innovation resulting in minimal hospital stay are major factors limiting the growth of the Latin American infection control market.
Concerns over the safety of reprocessed instruments such as catheters, lack of infection control programs, increasing use of outpatient procedures, increasing use of disposable medical items are expected to restrict the Latin American infection control market during the forecast period.
Impact of COVID-19 on the Latin American Infection Control Market:
With the severe outbreak of COVID-19, there is an unprecedented global demand for advanced health facilities, services, and infrastructure to treat those infected. As one of the essentials of healthcare, infection control products, such as personal protective equipment, are experiencing increasing demand in most countries worldwide to handle an increase in the number of COVID patients.
Healthcare workers depend on personal protective equipment to protect themselves and their patients from the infection and infection of others. However, with the COVID-19 pandemic crisis increasing dramatically, manufacturers are not responding sufficiently to the need to control infections through the use of disposable gowns and gloves, and the global healthcare industry is experiencing a shortfall in numbers. As a result, the World Health Organization (WHO) estimates that 90 million medical masks will be needed each month.
To meet this demand, a 41% increase in manufacturing is expected. Therefore, there will be an increase in infection control in Latin America during the forecast period.
This research report on the Latin American infection control market has been segmented and sub-segmented into the following categories.
By Products and Services:
Geographically, countries such as Brazil, Mexico, and Argentina are expected to occupy most of the share in the Latin American infection control market during the forecast period. The factors driving the growth of the Argentinian infection control market are the accelerated economic growth of many countries, the increasing attention of the government in the health sector, the increase in the prevalence of chronic diseases, the COVID-19 epidemic, the investment of government agencies for the expansion of health care facilities and favorable regulatory reforms.
The Brazilian infection control market is expected to be another lucrative regional market in Latin American during the forecast period. Brazil was plagued by the burden of acute infections among patients, affecting their safety. This has resulted in suffering, pain, delayed healing, increased use of antibiotics, revision surgery, increased length of hospital stays, morbidity, and mortality rates. It has also increased health spending. Therefore, institutional surveillance was implemented by the Brazilian Ministry of Health to meet the growing need to control nosocomial infections, and it has been practiced since then. In addition, the ministry has made it compulsory to set up an IAS control committee in public and private hospitals. These factors are driving the growth of the Brazilian infection control market.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in the Latin American infection control market profiled in this report are 3M, Dr. Wiegert, Tuttnauer, STERIS Corporation, Advanced Sterilization Products, Ecolab, Belimed AG, Cantel Medical Corporation, Matachana Group, Shinva Medical Instrument Co., Ltd., Whiteley Corporation, Ruhof Corporation, Getinge Group, and MMM Group.